CN1265821C - Medicine for treating liver cancer and its preparation method - Google Patents
Medicine for treating liver cancer and its preparation method Download PDFInfo
- Publication number
- CN1265821C CN1265821C CN 200310125405 CN200310125405A CN1265821C CN 1265821 C CN1265821 C CN 1265821C CN 200310125405 CN200310125405 CN 200310125405 CN 200310125405 A CN200310125405 A CN 200310125405A CN 1265821 C CN1265821 C CN 1265821C
- Authority
- CN
- China
- Prior art keywords
- portions
- herba
- radix
- medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a Chinese drug preparation, particularly to a drug for treating liver cancer and a preparation method thereof. The present invention is characterized in that the drug is composed of the following constituents with a weight proportion: 15-20 portions of semiaquilegia adoxoides, 20-25 portions of Japanese thistle herb, 30-40 portions of snake tongue grass, 30-40 portions of barbated skullcup herb, 20-30 portions of Japanese milkwort, 30-40 portions of elephantopus, 15-20 portions of climbing nightshade, 20-30 portions of Indian strawberry, 30-40 portions of raw astragalus, 10-20 portions of ginseng, 10-15 portions of vietnamese sophora roots, 15-20 portions of red sage roots and 10-15 portions of eupatorium; after the constituents of the drug are dried by air, the constituents are mixed, pulverized and ripened, and the preparation is manufactured after germicidal treatment by high temperature. Because drugs as the constituents are all plants without chemical composition, the present invention has no toxin or harm to a human body; the drug has good effect by taking frequently after symptomatic treatment according to clinical verification; the life of liver cancer patient can be prolonged, the life of a part of the patients can be prolonged for more than 10 years, and the pain of the patients can be relieved.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, particularly a kind of treatment liver-cancer medicine and preparation method.
Background technology
At present, hepatocarcinoma is one of common cancer, the branch of active property and Secondary cases, pathogeny often is because patient's body general immunity hypofunction or hepatitis, liver cirrhosis, hepatitis B medical history are arranged, and HBsAg is positive or feed contains the foods such as rice, corn, Semen arachidis hypogaeae of aflatoxin, nitrosamine compound, causes hepatocyte to cancerate and send out.Early symptom is not obvious, rarely seen upper right abdominal distention and pain, the hard and nodosity of the matter that press at the liver position, poor appetite, the time low grade fever is arranged, emaciated physique, shallow complexion or greyish black, symptoms such as jaundice, bleeding from the gum, melena, ascites.It is reported, China suffer from this type of patient have up to a million more than, and the trend that increases is arranged year by year, really hear the cancer complexion changed.Doctor trained in Western medicine has radiotherapy, chemotherapy, interventional therapy etc., excision and take Western medicine at the treatment liver cancer, though means are good, treat properly, but weak point is arranged also, as radiotherapy and chemotherapy, cancerous cell on the liver lesion is eliminated, but perilesional normal cell is also eliminated, and toxic and side effects is big, bluish white, the alopecia of patient's face, the existing QI and blood deficiency of patient's this moment is described, the performance of immunologic hypofunction.If cancerous cell shifts, the effect that then above-mentioned therapy is difficult to play.
Summary of the invention
The objective of the invention is at the deficiency on the present western medical treatment, a kind of treatment liver-cancer medicine and preparation method are provided.
The objective of the invention is to finish in the following manner: for many years, I verify the hepatocarcinoma clinical application, according to traditional Chinese medical science differentiation of eight pricipales, set upright and be principle from disappear knot, reinforcing of equilibrium between yin and yang, blood circulation promoting and blood stasis dispelling, depressed liver-energy dispersing and QI regulating, the carbuncle of loosing, adopt treatment by Chinese herbs hepatocarcinoma, through the many cases clinical verification, respond well, survival rate reached more than 10 years, and is that have even longer.The prescription of treatment by Chinese herbs hepatocarcinoma is by following medicaments in part by weight: Radix Semiaquilegiae 15-20 part, Radix Cirsii Japonici 20-25 part, Herba Hedyotidis Diffusae 30-40 part, Herba Scutellariae Barbatae 30-40 part, Herba Polygalae Japonicae 20-30 part, Herba Ajugae bracteosae 30-40 part, Herba Solani Lyrati 15-20 part, Herba Duchesneae Indicae 20-30 part, Radix Astragali 30-40 part, Radix Ginseng 10-20 part, Radix Sophorae Tonkinensis 10-15 part, Radix Salviae Miltiorrhizae 15-20 part, Herba Lycopi 10-15 part.After said medicine was air-dry, mixing was pulverized, and ripening then, high temperature sterilize are handled and made.
Said preparation method is: with the medicine in each component air-dry after, mixing is ground into 120-200 order fineness, carries out the ripening sterilization treatment 10-30 minute at 100 ℃-110 ℃, obtains the powder medicine.
Said powder medicine can be made into the solid block dosage form of cookies size, need add an amount of binding agent in the manufacturing process, and compression moulding then with vacuum packaging, can obtain bulk block dosage form.
Advantage of the present invention is because the prescription Chinese medicine all is plants, and no chemical analysis is nontoxic to human body.This medicine of informal dress is respond well through clinical verification behind the symptomatic treatment, prolongs the life-span of liver cancer patient, alleviates patient's misery.
The specific embodiment
Earlier various Chinese herbal medicine nature and flavor and effect in the prescription are done an analysis:
The medicine name | Nature and flavor | Effect |
Radix Semiaquilegiae | Sweet cold | Detumescence, eliminating stagnation |
Radix Cirsii Japonici | Sweet cold | Cooling blood for hemostasis, blood stasis dispersing and deswelling |
Herba Hedyotidis Diffusae | Sweet light cold | Heat-clearing and toxic substances removing, eliminating carbuncle |
Herba Scutellariae Barbatae | Xin Han | Heat-clearing and toxic substances removing, inducing diuresis to remove edema |
Herba Polygalae Japonicae | Arduous flat | Blood circulation promoting and blood stasis dispelling, calm the nerves |
Herba Ajugae bracteosae | Bitter cold | Heat-clearing and toxic substances removing, inducing diuresis to remove edema |
Herba Solani Lyrati | Hardship is slightly cold | Heat-clearing and toxic substances removing, diuresis |
Herba Duchesneae Indicae | Sweetness and bitterness is cold | Heat-clearing and toxic substances removing, eliminating stagnation |
Radix Astragali | Sweet tepor | Tonifying Qi and lifting yang |
Radix Ginseng | Sweet flat | Strongly invigorating primordial QI, tonifying the lung strengthening the spleen, calm the nerves |
Radix Sophorae Tonkinensis | Bitter cold | Heat-clearing and toxic substances removing |
Radix Salviae Miltiorrhizae | Hardship is slightly cold | Blood circulation promoting and blood stasis dispelling, removing heat from blood nourish blood, calm the nerves |
The Herba Lycopi | The toil tepor | Blood circulation promoting and blood stasis dispelling stimulates the menstrual flow |
Embodiment: the preparation prescription, with weight portion: 20 parts of Radix Semiaquilegiaes, 25 parts of Radix Cirsii Japonicis, 40 parts of Herba Hedyotidis Diffusaes, 40 parts of Herba Scutellariae Barbataes, 30 parts of Herba Polygalae Japonicae, 40 parts of Herba Ajugae bracteosaes, 20 parts of Herba Solani Lyratis, 30 parts of Herba Duchesneae Indicaes, 40 parts of Radix Astragali, 20 parts of Radix Ginsengs, 15 parts of Radix Sophorae Tonkinensiss, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts of Herba Lycopi.With said herbal medicine air-dry after, mixing is ground into 120-200 order fineness, carries out the ripening sterilization treatment 10-30 minute under 100 ℃-110 ℃, obtains the powder medicine, as makes the solid block dosage form, need to add an amount of binding agent, compression moulding again.Vacuum-packed then, obtain bulk block dosage form.
This prescription is suitable for diseases such as hepatitis B, hepatocarcinoma, pulmonary carcinoma, intestinal cancer.Instructions of taking: the patient takes 3-4 time every day, each 30 grams, warm water delivery service.After taking 15 days, self-induction is comfortable from head to foot, and is free and relaxed, take continuously, but anticancer divides transfer, reaches the purpose of life-saving.Period in a medicine, the patient must absolutely no smoking drinks and pungent stimulation article.Should have more meals a day but less food at each, polyphagia is with high fiber and contain protein rich food, when muscle power allows, but moderate exercise.
Claims (3)
1, a kind of treatment liver-cancer medicine, it is characterized in that by following medicaments in part by weight: Radix Semiaquilegiae 15-20 part, Radix Cirsii Japonici 20-25 part, Herba Hedyotidis Diffusae 30-40 part, Herba Scutellariae Barbatae 30-40 part, Herba Polygalae Japonicae 20-30 part, Herba Ajugae bracteosae 30-40 part, Herba Solani Lyrati 15-20 part, Herba Duchesneae Indicae 20-30 part, Radix Astragali 30-40 part, Radix Ginseng 10-20 part, Radix Sophorae Tonkinensis 10-15 part, Radix Salviae Miltiorrhizae 15-20 part, Herba Lycopi 10-15 part, after air-dry, mixing is pulverized, and ripening then, high temperature sterilize are handled and made.
2, a kind of preparation method for the treatment of liver-cancer medicine, it is characterized in that by weight: Radix Semiaquilegiae 15-20 part, Radix Cirsii Japonici 20-25 part, Herba Hedyotidis Diffusae 30-40 part, Herba Scutellariae Barbatae 30-40 part, Herba Polygalae Japonicae 20-30 part, Herba Ajugae bracteosae 30-40 part, Herba Solani Lyrati 15-20 part, Herba Duchesneae Indicae 20-30 part, Radix Astragali 30-40 part, Radix Ginseng 10-20 part, Radix Sophorae Tonkinensis 10-15 part, Radix Salviae Miltiorrhizae 15-20 part, Herba Lycopi 10-15 part each component, after said medicine is air-dry, mixing is ground into 120-200 order fineness, under 100 ℃-110 ℃, carry out the ripening sterilization treatment 10-30 minute, obtain the powder medicine.
3, according to the said a kind of preparation method for the treatment of liver-cancer medicine of claim 2, it is characterized in that the powder medicine can be made into the solid block dosage form of cookies size, need add an amount of binding agent, compression moulding then in the manufacturing process, with vacuum packaging, can obtain bulk block dosage form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310125405 CN1265821C (en) | 2003-12-31 | 2003-12-31 | Medicine for treating liver cancer and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200310125405 CN1265821C (en) | 2003-12-31 | 2003-12-31 | Medicine for treating liver cancer and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1555844A CN1555844A (en) | 2004-12-22 |
CN1265821C true CN1265821C (en) | 2006-07-26 |
Family
ID=34339014
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200310125405 Expired - Fee Related CN1265821C (en) | 2003-12-31 | 2003-12-31 | Medicine for treating liver cancer and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1265821C (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311752C (en) * | 2005-02-21 | 2007-04-25 | 鲁汝协 | Healthy tea and its preparing method |
CN103445230A (en) * | 2013-07-29 | 2013-12-18 | 宫中利 | Anti-cancer red melon seed and preparation method thereof |
-
2003
- 2003-12-31 CN CN 200310125405 patent/CN1265821C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1555844A (en) | 2004-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101787432B1 (en) | Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate | |
CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
CN102940808A (en) | Prescription medicine for treating lung cancer and preparation method | |
CN1265821C (en) | Medicine for treating liver cancer and its preparation method | |
CN108030071A (en) | A kind of preparation method of dietotherapy product formula, its preparation method and dietotherapy cake | |
CN112220901A (en) | Traditional Chinese medicine drop and preparation method thereof | |
CN106668409A (en) | Hui traditional Chinese medicine hedyotis diffusa willd anti-esophageal cancer oral liquid and preparation method thereof | |
CN104840902A (en) | Traditional Chinese medicine preparation for treating ovarian tumor | |
CN108785575A (en) | A kind of Chinese herbal ointment formula | |
CN107412657A (en) | The Chinese medicine composition of invigorating qi and benefiting blood anti-aging | |
CN106668494A (en) | Hui nationality traditional Chinese medicine astragalus membranaceus root stomach cancer-dispersing granules and preparation method thereof | |
CN106309698A (en) | Traditional Chinese medicine composition for treating ichthyosis and preparation method thereof | |
CN105535501A (en) | Traditional Chinese medicine for treating cancer | |
CN105770760A (en) | Preparation for treating gastric ulcer and preparation method thereof | |
CN105748968A (en) | Medicine pills for adjuvant therapy of megaloblastic anemia and preparation method thereof | |
CN104095986A (en) | Traditional Chinese medicine composition for treating cheilitis | |
CN111617228A (en) | Traditional Chinese medicine for treating gallstones, preparation method and application thereof | |
CN100361698C (en) | Medicinal Wushan powder for treating stamach disease | |
CN111643653A (en) | Traditional Chinese medicine for treating kidney stone and gall-stone, preparation method and application thereof | |
CN106668622A (en) | Hui nationality traditional Chinese medicine flower-root particles for treating gastric cancer and preparation method thereof | |
CN106668618A (en) | Hui nationality traditional Chinese medicinal Levant Cotton Root stomach cancer treatment pill and preparation method thereof | |
CN106668729A (en) | Hui-nationality traditional Chinese medicine pill with curcuma zedoary and semen cuscutae for treating gastric cancer and preparation method thereof | |
CN106668617A (en) | Hui-nationality traditional Chinese medicine levant cotton root tablets for treating gastric cancer and preparation method thereof | |
CN106668421A (en) | Hui-nationality traditional Chinese medicine granule with herba hedyotidis diffusae for resisting esophagus cancer and preparation method thereof | |
CN106668377A (en) | Hui traditional Chinese medicine fiveleaf akebia fruit anti-esophageal cancer pill and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060726 Termination date: 20101231 |